AzTrials
AzTrials

Mindfulness ProtocolsNCT07364032

Comparison Between a Mindfulness-Based Program and Standard Therapeutic Follow-Up During Pregnancy

A study testing Mindfulness program and Consultations in people with Mindfulness Protocols and Pregnancy, run by Universite Cote d'Azur at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program. Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Mindfulness Protocols, Pregnancy
What is being tested?
Mindfulness program and Consultations
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
1 siteFrance
Study dates
31 Mar 2023to 26 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Pregnant women between 3 and 7.5 months of gestation (12-28 weeks).
  • Ability to speak and read French sufficient to understand study documents and complete questionnaires.
  • Willingness to participate in the study and to be randomized to one of the study groups.

Who cannot join

  • Loss of the baby
  • Participation in other prenatal support programs, including prenatal yoga, haptonomy, sophrology, or mindfulness courses.
  • Severe or unstable psychiatric disorder. Inability to understand French or complete study questionnaires.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Clara Beauvois Cabinet de psychologie

    Mouans-Sartoux, 06370

Other trials in France

About this study

Official title: A Randomized Controlled Trial Comparing a Mindfulness-based Program With Standard Therapeutic Follow-up During Pregnancy: Effects on Maternal Well-being, Infant Outcomes, and Mother-Infant Attachment

This study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program.

Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week.

Read more

The primary objectives are to determine whether the mindfulness program leads to:

Reduced negative affect, including stress, anxiety, depression, and sleep disturbances during pregnancy.

Increased positive affect, such as mindfulness skills, self-efficacy, happiness, and life satisfaction.

Enhanced maternal-fetal attachment during pregnancy and improved maternal-infant attachment one month postpartum.

Improved mother-infant interaction quality at 3 months postpartum.

More secure infant attachment at 12 months.

Better infant outcomes, including reduced crying intensity/duration at 1 and 3 months, and improved sleep quality at 12 months.

Overall, the study evaluates whether the mindfulness program provides greater benefits than a standard parenting support intervention.

Being tested
Mindfulness program, Consultations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness programBehavioural

    6 weeks of mindfulness

  • ConsultationsOther

    6 week of consultation with 1 consultation per week

Study groups in NCT07364032
Study groupRoleWhat they receive
Mindfulness programExperimentalNot described
Receives: Behavioral: Mindfulness program
ClassicalSham comparatorNot described
Receives: Other: Consultations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety

    French version of Pregnancy Related Anxiety Questionnaire (Reymond et al., 2020)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  2. Stress

    French version of Short Stress scale (Cungi et al., 2003)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  3. Depression

    French version of Edinburgh Postnatal Depression Scale, (Cox et al., 1987)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  4. Sleep disorders

    French version of The Pittsburgh sleep quality index, (Buysse et al., 1989)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  5. Mindfulness

    French version of Mindfulness Scale (Brown et Ryan., 2003)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  6. Self efficacy

    French version of Generalized Self-Efficacy scale (Schwarzer et al., 1995)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  7. Happiness

    French version of Subjective Happiness Scale (Lyubomirsky \& Lepper, 1997)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  8. Satisfaction of life

    French version of The Satisfaction with Life Scale (Diener et al., 1985)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

  9. Prenatal Attachment

    French version of Prenatal Attachment Inventory, (Muller, 1993)

    Measured: Questionnaire will be completed at day 0 and 6 weeks later.

Secondary outcomes (3)
  1. Cries of the baby

    French Version Colic infant questionnaire (Bellaiche et al., 2021)

    Measured: Questionnaires will be completed daily up to 1 and 3 months post partum

  2. Sleep disturbances

    French Version Sleep disturbance scale for children, (Lecuelle et al., 2020)

    Measured: Questionnaires will be completed at 1 year Post partum

  3. Post natal attachment

    French version of Baby Interaction Scale (Beaupuy. 2021) Pediatric Infant Parent Exam (PIPE, Fiese et al., 2001)

    Measured: video at 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2026
  2. Study start31 Mar 2023
  3. Primary completion26 Aug 2026
  4. Study completion26 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07364032
Sponsor's protocol ID
CB-PCG-2022
Other IDs
ANR-15-IDEX-01
Status last verified
Aug 2026
First submitted
9 Dec 2025
Last updated
31 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Beauvois C, Soubelet A. A randomized controlled trial comparing a mindfulness-based program with standard therapeutic follow-up during pregnancy: Effects on maternal mental health, infant outcomes, and mother-infant attachment. Contemp Clin Trials. 2026 Jul 8;168:108401. doi: 10.1016/j.cct.2026.108401. Online ahead of print.

    PubMed 42419504

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness program and Consultations in people with Mindfulness Protocols and Pregnancy, run by Universite Cote d'Azur at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety (time frame: Questionnaire will be completed at day 0 and 6 weeks later.). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07364032, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in